InvestorsHub Logo
Followers 0
Posts 3727
Boards Moderated 0
Alias Born 10/23/2017

Re: None

Thursday, 09/27/2018 2:58:40 PM

Thursday, September 27, 2018 2:58:40 PM

Post# of 698624
The Nature article has a quote from Liau on the intriguing results of the phase 3 trial, then there is this line later in the article: "Buzz has been building around another personalized-vaccine effort that has shown hints of improved survival. The DCVax-L strategy from Northwest Biotherapeutics in Bethesda, Maryland, entails training dendritic cells with protein extracts derived from tumors. Researchers who are collaborating with the company on a phase III trial reported that 100 of the 331 people who were treated are still alive 40 months later.

Maybe it will take a few days to get circulated and get attention? Or, are we in a place where no matter what is said about NWBO, even if it is positive, no one will touch it until they release top line data??
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News